***Background.*** High levels of interferon gamma-induced protein (IP10) associate with rapid disease progression, chronic immune activation and HIV-1 replication in adults; however, the association of this cytokine with HIV disease in perinatally HIV infected children and adolescents, is not established.

***Methods.*** We measure plasma IP10 levels by Luminex and CD8+ T cell activation (HLA-DR+ and CD38+) by flow cytometry. HIV+ patients are parsed into viremic (n = 28) and aviremic (n = 11) (HIV RNA \< 400 or ≥ 400 copies/ml). Wilcoxon rank-sum is used to compare groups and Spearman\'s coefficient is used for correlation analysis.

###### 

Immunologic parameters

  Outcome         HIV- ^‡^             Aviremic ^‡^          Viremic ^‡^             *p*
  --------------- -------------------- --------------------- ----------------------- ------------
  IP10 \*         182.1(118.2-227.6)   485.9 (289.7-976.1)   1086.9 (425.8-2408.6)   \<0.001^†^
  CD4+ %                               30.9 (23.2-39.2)      28.0 (19.0-39.0)        \-
  CD8+ %                               35.2 (30-47)          47.2 (32.4-54.1)        \-
  CD8+CD38+ %                          12.0 (8.0-14)         20.5 (16.0-34.0)        0.001
  CD8+HLA-DR+ %                        10.0 (4.0-21)         23.0 (14.0-33.0)        0.01

###### 

Correlation analysis

                   IP10    Early cARV therapy           
  ---------------- ------- -------------------- ------- -----------
  Outcome          r       *p*                  r       *p*
  CD4 %            -0.57   **\<0.001**          -0.50   **0.001**
  CD8 %            0.43    **0.01**             0.47    **0.002**
  CD8+CD38+ %      0.37    **0.04**             0.13    0.43
  CD8+ HLA+DR+ %   0.53    **0.002**            0.32    **0.04**
  IP10                                          0.37    **0.03**

\*pg/ml; ‡ median (IQR), † Viremic vs HIV-.

***Results.*** 39 HIV+ on cARV \[median CD4 % 30.2 IQR (23.2-39.4) and HIV RNA1.8 log~10~(1.6-3.0) copies/ml\] and 14 HIV- are studied. HIV+ have significant higher concentrations of IP10 compared with HIV- (P \< 0.0001); especially viremic individuals (Table 1). We observe significantly higher % of T cell activation markers in viremic compared with aviremic (Table 1). Higher levels of IP10 correlate with higher CD38 % and HLA-DR and lower CD4 % (Table 2). Lastly, early cARV therapy correlates with lower levels of IP10, CD8 %, CD8+ HLA-DR %, and higher CD4 % (Table 2).

***Conclusion.*** Perinatally HIV infected children and adolescents have a pattern of IP10 elevation comparable to HIV infected adults. Notably, IP10, a product of monocytes and dendritic cells, is significantly elevated-especially in viremic children- and associates with T cell activation and low CD4 %. The results support the view that IP10 is secreted in part as a direct effect of viral replication. Furthermore, our data suggest that early initiation of cARV might help to prevent immune system activation and disease progression in this population.
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